The renowned European Respiratory Society (ERS) is one of the leading European non-profit professional organizations in the area of respiratory diseases, with some 10,000 members in over 100 countries. It recently assessed Pelargonium as a recommended treatment for acute bronchitis. About 90% of cases of acute bronchitis and other respiratory tract infections are caused by viruses. Despite the fact that there is no or very little therapeutic benefit from antibiotics in cases of viral infections, there is still a strong tendency to prescribe antibiotics for these mostly uncomplicated respiratory tract infections. But the use of antibiotics bears the risk of bacterial resistance that may be quite dangerous.
The recommendation published within this guideline* clearly states that antibiotics should not be used routinely for acute bronchitis. Furthermore antitussives are not recommended in children nor are expectorants recommended in adults.
At the same time, Pelargonium extract is one of the recommended medications for acute bronchitis due to its benefits in symptomatic relief and faster recovery. This has been shown in several placebo-controlled clinical trials. These clinical trials have all been conducted with EPs® 7630, a special root extract from Pelargonium sidoides.
* (Vol. 60 of the ERS Monograph 2013, “The Spectrum of Bronchial Infection”, chapter 1)